NECCHI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 1.041
NA - Nord America 928
AS - Asia 843
SA - Sud America 79
AF - Africa 24
Totale 2.915
Nazione #
US - Stati Uniti d'America 908
DE - Germania 480
SG - Singapore 231
CN - Cina 211
GB - Regno Unito 206
VN - Vietnam 163
BD - Bangladesh 122
IT - Italia 111
BR - Brasile 62
HK - Hong Kong 48
RU - Federazione Russa 48
SE - Svezia 48
FR - Francia 39
NL - Olanda 30
CI - Costa d'Avorio 19
FI - Finlandia 17
IE - Irlanda 17
IN - India 14
KR - Corea 13
CA - Canada 12
JP - Giappone 10
AR - Argentina 8
PL - Polonia 8
BE - Belgio 7
ES - Italia 6
IQ - Iraq 6
UA - Ucraina 6
AT - Austria 4
DK - Danimarca 4
ID - Indonesia 4
JM - Giamaica 4
SA - Arabia Saudita 4
TR - Turchia 4
ZA - Sudafrica 4
EC - Ecuador 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
GR - Grecia 2
IL - Israele 2
LT - Lituania 2
MY - Malesia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GY - Guiana 1
JO - Giordania 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.915
Città #
Frankfurt am Main 427
Southend 158
Chandler 140
Singapore 138
Ashburn 102
Dallas 88
San Jose 62
Hong Kong 44
Hanoi 41
Munich 38
Beijing 37
Ho Chi Minh City 37
Milan 36
Santa Clara 35
Seattle 32
Wilmington 28
New York 25
Princeton 24
Boardman 21
Council Bluffs 20
Moscow 20
Abidjan 19
Ann Arbor 19
Los Angeles 19
Dublin 17
Fairfield 17
Lauterbourg 17
Buffalo 16
Columbus 16
Da Nang 15
Phoenix 12
Falls Church 10
Nanjing 10
Tokyo 10
Des Moines 9
Rome 9
The Dalles 9
São Paulo 8
Bengaluru 7
Brussels 7
Bến Tre 7
Guangzhou 7
Haiphong 7
Jinan 7
Changsha 6
Fuzhou 6
Houston 6
Woodbridge 6
Bari 5
London 5
Naples 5
San Diego 5
Shenyang 5
Toronto 5
Amsterdam 4
Belo Horizonte 4
Catania 4
Chicago 4
Kent 4
Seoul 4
Thái Bình 4
Warsaw 4
Baghdad 3
Brooklyn 3
Cangzhou 3
Dresden 3
Eitensheim 3
Go Vap 3
Hangzhou 3
Helsinki 3
Kunming 3
Madrid 3
Montreal 3
Redwood City 3
Turku 3
Tân Tiến 3
Wanghailou 3
Wroclaw 3
Ancona 2
Boston 2
Buenos Aires 2
Cambridge 2
Campinas 2
Can Tho 2
Charlotte 2
Chengdu 2
Denver 2
Dhaka 2
Florence 2
Guayaquil 2
Hai Bà Trưng 2
Haikou 2
Hebei 2
Hefei 2
Huế 2
Jeddah 2
Jiaxing 2
Johannesburg 2
Kuala Lumpur 2
Manchester 2
Totale 2.005
Nome #
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 275
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 257
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation 254
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma 243
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy 235
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes 216
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial 214
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer 208
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma : a systematic review and meta-analysis of patient outcomes 206
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer : an open label, single-group, phase 2 trial 197
Immunotherapy advances in uro-genital malignancies 192
Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment 187
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†[Formula presented]: Under the Auspices of the EAU-ESMO Guidelines Committees 157
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees 152
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 37
Emerging treatment landscape of non-muscle invasive bladder cancer 2
Totale 3.032
Categoria #
all - tutte 7.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022147 3 1 3 2 10 12 6 5 7 17 17 64
2022/2023263 32 45 32 39 9 34 7 17 41 1 3 3
2023/2024360 3 6 5 7 30 3 59 51 24 52 58 62
2024/2025544 54 51 43 78 37 9 4 33 31 55 63 86
2025/20261.214 103 33 157 80 98 64 187 37 76 89 195 95
Totale 3.032